MedTrace Logo

Blood Flow Restriction Training in Basketball Players

NCT06420362 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-08-05

No results posted yet for this study

Summary

Blood Flow Restrictive Exercises (BFR) provide strength increase with less load than required for traditional muscle strengthening and power. As an alternative for populations that have difficulty training with high loads and speeds, low-intensity BFR training has been shown to improve muscle strength and aerobic parameters and to be safe, even in professional athletes and individuals with chronic diseases in various populations. The aim of our study is to examine the effects of BFR applied to the upper extremity on upper extremity muscle strength and performance in basketball players.

Conditions

  • Basketball Players

Interventions

OTHER

Blood Flow Restriction

Before BFR training, a repetition maximal (1-RM) test will be determined by selecting a weight with which athletes can perform a maximum of 10 repetitions. The number of repetitions obtained here and the weight lifted will be written into the Brzycki formula, whose validity and reliability has been proven, and 1-TM will be calculated. Brzycki formula; 1-TM = \[100 x (Weight Lifted) / \[(102.78 - 2.78 x (Number of Reps)\] The arterial occlusion pressure of the participants will be measured with a Doppler Ultrasound device by increasing the cuff to the point where the auscultatory pulse of the brachial artery ceases until occlusion occurs in the brachial artery. Then, 60% of this value will be calculated and BFR will be performed during the exercises.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Principal Investigators

  • Buket AKINCI, Assoc.Prof. · Biruni University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-02
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06420362 on ClinicalTrials.gov